Welltower (WELL)
(Delayed Data from NYSE)
$127.58 USD
-0.45 (-0.35%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $127.63 +0.05 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$127.58 USD
-0.45 (-0.35%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $127.63 +0.05 (0.04%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Zacks News
Why Is Welltower (WELL) Down 3.8% Since Last Earnings Report?
by Zacks Equity Research
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Welltower (WELL) Shares Gain 10.5% in Past 6 Months
by Zacks Equity Research
Improving SHO portfolio fundamentals, portfolio restructuring initiatives and capital recycling efforts drive Welltower's (WELL) shares 10.5% up in the past six months.
Ventas' (VTR) Q1 FFO and Revenues Beat, SHOP NOI Increases
by Zacks Equity Research
Ventas's (VTR) Q1 earnings outshine estimates on better-than-anticipated revenues. The SHOP same-store cash NOI improves on strong pricing power and margin expansion. The company maintains its 2023 outlook.
Ventas (VTR) to Post Q1 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Ventas' (VTR) Q1 earnings are likely to have benefited from the positive operating trends of its senior housing operating portfolio and high demand for life-science real-estate assets.
Host Hotels' (HST) Q1 FFO & Revenues Beat, '23 View Raised
by Zacks Equity Research
Host Hotels' (HST) Q1 earnings outshine estimates on better-than-anticipated revenues, aided by continued strong leisure travel demand and growth in city center markets. It also raises its 2023 outlook.
Welltower (WELL) Q1 FFO Tops, SHO Occupancy Up, '23 View Raised
by Zacks Equity Research
Welltower's (WELL) Q1 earnings outshine estimates on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year. The company raises its 2023 FFO per share outlook.
Welltower (WELL) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Welltower (WELL) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Welltower (WELL) Q1 FFO and Revenues Beat Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 3.66% and 1.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is a Beat in the Cards for Welltower (WELL) in Q1 Earnings?
by Zacks Equity Research
Welltower's (WELL) Q1 earnings are likely to have benefited from the positive operating trends in the seniors housing operating portfolio.
Vornado (VNO) to Post Q1 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Despite declining office-space demand, Vornado's (VNO) Q1 earnings are likely to have benefited from the healthy demand for its flight-to-quality office properties.
Key Factors to Impact Medical Properties' (MPW) Q1 Earnings
by Zacks Equity Research
Improving operating fundamentals of its tenants are likely to have aided Medical Properties' (MPW) Q1 earnings. However, higher interest expenses and exposure to troubled operators might have ailed.
What's in Store for SBA Communications (SBAC) in Q1 Earnings?
by Zacks Equity Research
High demand for SBA Communications' (SBAC) wireless infrastructure assets amid 5G deployment efforts by carriers is likely to have aided its Q1 earnings. However, rising interest expenses are a woe.
Is a Beat in Store for Digital Realty (DLR) in Q1 Earnings?
by Zacks Equity Research
Solid data-center demand amid enterprises' growing reliance on technology and acceleration in digital transformation strategies might have aided Digital Realty's (DLR) Q1 earnings.
Is a Beat in Store for American Tower (AMT) in Q1 Earnings?
by Zacks Equity Research
Robust demand for American Tower's (AMT) communications real estate portfolio amid global 5G deployment efforts by wireless carriers is likely to have aided its Q1 earnings.
Healthpeak (PEAK) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Robust demand for Healthpeak's (PEAK) life-science assets and rising healthcare spending by senior citizens are likely to have aided its Q1 earnings. However, rising interest rates might have ailed.
What's Going On With Block Shares?
by Derek Lewis
Block shares are making headlines for all the wrong reasons today, with short-seller Hindenburg Research raising red flags surrounding the company. Whose side are you on?
Welltower (WELL) Down 9.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is it Wise to Hold on to Healthpeak (PEAK) Stock for Now?
by Zacks Equity Research
Healthpeak's (PEAK) focus on enhancing its life-science real-estate assets, capital-recycling moves and a solid balance sheet bodes well. Stiff competition from peers and rising interest rates are woes.
Welltower (WELL) Q4 FFO & Revenues Beat, SHO Occupancy Rises
by Zacks Equity Research
Welltower's (WELL) Q4 results gain on better-than-anticipated revenues. The SHO portfolio occupancy improves year over year. The company issues its 2023 outlook.
Welltower (WELL) Surpasses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 1.22% and 1.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Welltower (WELL) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Positive operating trends in the SHO portfolio are likely to have aided Welltower's (WELL) Q4 earnings. However, rising interest rates and a stronger U.S. dollar might have been a spoilsport.
Is it Wise to Hold on to Welltower (WELL) Stock for Now?
by Zacks Equity Research
Welltower's (WELL) diversified portfolio of healthcare assets, strategic repositioning efforts and strong balance sheet bode well. Stiff competition and rising interest rates are key concerns.
Welltower (WELL) Rallies 15% in Past Three Months: Here's Why
by Zacks Equity Research
Welltower's (WELL) restructuring initiatives, improving seniors housing operating portfolio fundamentals and capital recycling efforts drive a 15% increase in its share price.
Welltower (WELL) Closes First Tranche of JV With Integra
by Zacks Equity Research
Welltower (WELL) enters a master lease with Integra for the entire 147-property skilled nursing portfolio. It also sells 15% interest in 54 skilled nursing assets to Integra for $73 million.
Welltower (WELL) Up 2.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.